Skip to content

Characteristics of prospective participants and participants in a SARS-CoV-2 vaccination trial (phase I-III): demographics, motivation, attitudes to risk and new technologies

Characteristics of prospective participants and participants in a SARS-CoV-2 vaccination trial (phase I-III): demographics, motivation, attitudes to risk and new technologies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00025242
Enrollment
220
Registered
2021-05-21
Start date
2021-05-24
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Interventions

Group 1: Participants Screen Failures Interested Persons

Sponsors

Tropeninstitut am LMU Klinikum
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definition of Participant (Phase I and Phase II/III): Administration of the investigational product/placebo on day 1 of the vaccination study. Definition of Screen Failure (Phase I and Phase II/III): Exclusion during screening at the trial site. Definition of Interested Person: Expression of interest in participation in vaccination study and provisioning of e-mail address. No invitation to screening. Inclusion criterion for online questionnaire: Belonging to one of the above-mentioned groups as well as completion and sending of the questionnaire.

Exclusion criteria

Exclusion criteria: Obviously incorrect/inconsistent completion of the questionnaire

Design outcomes

Primary

MeasureTime frame
Significant differences and correlations in demographics, motivation, and attitudes towards risk, communication and technologies both within and across collectives.

Secondary

MeasureTime frame
Correlation of the participants' risk behaviour with their self-assessment and comparison of the self-assessment with the total population. Checking the consistency of the stated motivation. Evaluation of the correlation between altruistic motivation and altruistic action.

Countries

Germany

Contacts

Public ContactAndreas Zeder

Tropeninstitut am LMU Klinikum

azeder@med.lmu.de089/4400-59854

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026